{"id":"https://openalex.org/W1994435019","doi":"https://doi.org/10.1007/s00280-014-2375-2","title":"Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors","display_name":"Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-18","ids":{"openalex":"https://openalex.org/W1994435019","doi":"https://doi.org/10.1007/s00280-014-2375-2","mag":"1994435019","pmid":"https://pubmed.ncbi.nlm.nih.gov/24442032","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3931937"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-014-2375-2","doi":"https://doi.org/10.1007/s00280-014-2375-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-014-2375-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-014-2375-2.pdf","source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994435019"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00280-014-2375-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011088302","display_name":"Hiroshi Wakui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroshi Wakui","raw_affiliation_strings":["Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030587345","display_name":"Noboru Yamamoto","orcid":"https://orcid.org/0000-0002-0787-2851","observed_orcids":["https://orcid.org/0000-0002-0787-2851"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Noboru Yamamoto","raw_affiliation_strings":["Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047912612","display_name":"Shinji Nakamichi","orcid":"https://orcid.org/0000-0002-2298-6945","observed_orcids":["https://orcid.org/0000-0002-2298-6945"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shinji Nakamichi","raw_affiliation_strings":["Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074573350","display_name":"Yousuke Tamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yousuke Tamura","raw_affiliation_strings":["Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020327537","display_name":"Hiroshi Nokihara","orcid":"https://orcid.org/0000-0002-1219-6966","observed_orcids":["https://orcid.org/0000-0002-1219-6966"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroshi Nokihara","raw_affiliation_strings":["Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079864042","display_name":"Yasuhide Yamada","orcid":"https://orcid.org/0000-0003-0692-8419","observed_orcids":["https://orcid.org/0000-0003-0692-8419"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuhide Yamada","raw_affiliation_strings":["Department of Gastrointestinal Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","Department of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"Department of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105411153","display_name":"Tomohide Tamura","orcid":"https://orcid.org/0000-0003-3601-8889","observed_orcids":["https://orcid.org/0000-0003-3601-8889"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tomohide Tamura","raw_affiliation_strings":["Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5105411153"],"corresponding_institution_ids":["https://openalex.org/I4405285273"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":3.3932,"has_fulltext":true,"cited_by_count":44,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93606232,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"73","issue":"3","first_page":"511","last_page":"516"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/patritumab","display_name":"patritumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.9010000228881836},{"id":"https://openalex.org/keywords/human-monoclonal-antibodies","display_name":"human monoclonal antibodies","score":0.8619999885559082},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8640000224113464},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8700000047683716},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9399999976158142},{"id":"https://openalex.org/keywords/anti-drug-antibody","display_name":"anti-drug antibody","score":0.7300000190734863},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.43799999356269836},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7873015403747559},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.7744170427322388},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.7643646597862244},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7134751081466675},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6892433166503906},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6668637990951538},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.622309148311615},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5108453631401062},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4948808550834656},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46995046734809875},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.45314061641693115},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.4283279776573181},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.42667779326438904},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40214240550994873},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.37274664640426636},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25164681673049927}],"mesh":[{"descriptor_ui":"D000080908","descriptor_name":"Broadly Neutralizing Antibodies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020893","descriptor_name":"Receptor, ErbB-3","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s00280-014-2375-2","doi":"https://doi.org/10.1007/s00280-014-2375-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-014-2375-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-014-2375-2.pdf","source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2923542","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3931937","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3931937","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3931937/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemother Pharmacol","raw_type":"Text"},{"id":"pmid:24442032","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24442032","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.815.2038","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.815.2038","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/08/7f/280_2014_Article_2375.PMC3931937.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s00280-014-2375-2","doi":"https://doi.org/10.1007/s00280-014-2375-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-014-2375-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-014-2375-2.pdf","source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1994435019.pdf","grobid_xml":"https://content.openalex.org/works/W1994435019.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1582187753","https://openalex.org/W1964321121","https://openalex.org/W1979563875","https://openalex.org/W1995097511","https://openalex.org/W1998971866","https://openalex.org/W2017081079","https://openalex.org/W2017290745","https://openalex.org/W2036253797","https://openalex.org/W2036562628","https://openalex.org/W2053673624","https://openalex.org/W2073604089","https://openalex.org/W2106567943","https://openalex.org/W2112853929","https://openalex.org/W2123206362","https://openalex.org/W2124511021","https://openalex.org/W2132405742","https://openalex.org/W2137399990","https://openalex.org/W2159639650","https://openalex.org/W2167241562","https://openalex.org/W2408927291","https://openalex.org/W2419437389","https://openalex.org/W2787560615","https://openalex.org/W2967097725"],"related_works":["https://openalex.org/W2315090353","https://openalex.org/W2133206502","https://openalex.org/W2603546330","https://openalex.org/W2583783944","https://openalex.org/W2496043878","https://openalex.org/W2599383640","https://openalex.org/W2313010431","https://openalex.org/W3000179854","https://openalex.org/W4387396499"],"abstract_inverted_index":{"PURPOSE:":[0],"Patritumab":[1,237],"(U3-1287)":[2],"is":[3],"a":[4,221],"human":[5],"epidermal":[6],"growth":[7],"factor":[8],"receptor-3":[9],"(HER3)-targeted":[10],"antibody":[11,234],"that":[12],"blocks":[13],"ligand-associated":[14],"activation":[15],"of":[16,35,159,224],"HER3.":[17],"This":[18],"open-label,":[19],"phase":[20,197],"1":[21,106,198],"and":[22,46,155,184],"dose-finding":[23],"study":[24],"(ClinicalTrials.jp":[25],"Identifier:":[26],"JapicCTI-101262)":[27],"aimed":[28],"to":[29,81,104,193,242],"assess":[30],"the":[31,82,101,194],"safety,":[32],"pharmacokinetics,":[33],"incidence":[34],"anti-patritumab":[36,233],"antibody,":[37],"recommended":[38],"dose":[39,103],"for":[40,89,232],"subsequent":[41],"clinical":[42,216],"studies,":[43],"preliminary":[44],"efficacy,":[45],"patritumab-related":[47],"biomarkers":[48],"in":[49,117,170,203,207,247,257],"Japanese":[50,248],"patients":[51,125,140,144,172,219,228,249],"with":[52,113,215,250],"advanced":[53,251],"solid":[54,252],"tumors.":[55,253],"METHODS:":[56],"Patients":[57],"received":[58,126],"patritumab":[59,127],"9":[60,128],"or":[61,71,133],"18":[62,134,243],"mg/kg":[63,129,135,244],"intravenously":[64],"every":[65],"3":[66],"weeks":[67],"until":[68],"disease":[69],"progression":[70],"intolerable":[72],"toxicity":[73],"occurred.":[74],"Adverse":[75,90],"events":[76],"(AEs)":[77],"were":[78,98,141,165,173],"assessed":[79,112],"according":[80],"National":[83],"Cancer":[84],"Institute":[85],"Common":[86],"Terminology":[87],"Criteria":[88,116],"Events":[91],"(CTCAE":[92],"version":[93,121],"4.0).":[94],"Dose-limiting":[95],"toxicities":[96],"(DLTs)":[97],"evaluated":[99],"from":[100],"initial":[102],"Cycle":[105],"Day":[107],"21.":[108],"Tumor":[109],"response":[110,223],"was":[111,191,238],"Response":[114],"Evaluation":[115],"Solid":[118],"Tumors":[119],"(RECIST":[120],"1.1).":[122],"RESULTS:":[123],"Nine":[124],"(n":[130,136],"=":[131,137],"3)":[132],"6).":[138],"Five":[139],"male,":[142],"all":[143,208,258],"had":[145,220,230],"Eastern":[146],"Cooperative":[147],"Oncology":[148],"Group":[149],"performance":[150],"status":[151],"(PS)":[152],"\u2264":[153],"1,":[154],"median":[156],"(range)":[157],"age":[158],"67":[160],"(50-69)":[161],"years.":[162],"No":[163],"DLTs":[164,246],"reported.":[166],"Patritumab-related":[167],"AEs":[168],"reported":[169],"\u22652":[171],"ALT":[174],"increase":[175,186],"(three":[176],"patients),":[177],"thrombocytopenia,":[178],"diarrhea,":[179],"stomatitis,":[180],"cheilitis,":[181],"rash":[182],"maculo-papular":[183],"AST":[185],"(two":[187],"each).":[188],"Pharmacokinetics":[189],"profile":[190],"similar":[192],"preceding":[195],"US":[196],"study.":[199],"Soluble":[200,254],"HER3":[201,255],"concentration":[202],"serum":[204],"unexpectedly":[205],"increased":[206,256],"patients.":[209,259],"These":[210],"changes":[211],"did":[212],"not":[213],"correlate":[214],"response.":[217],"Four":[218],"best":[222],"stable":[225],"disease.":[226],"All":[227],"tested":[229],"negative":[231],"formation.":[235],"CONCLUSIONS:":[236],"well":[239],"tolerated":[240],"up":[241],"without":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994435019","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
